47th Annual Gastroenterology Update: Biologic Therapies for Inflammatory Bowel Disease, Part 2
November 17th 2011Ahmed Kandiel, MD, MPH, at the Cleveland Clinic concluded his lecture, "Which Patient/Which Biologic," by reviewing the results of a recently published meta-analysis which examined the risks and benefits of biologic therapy for patients with moderate-to-severe IBD.
Read More